{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-092256","form_type":"8-K","ticker":"HLF","cik":"0001180262","company_name":"HERBALIFE LTD.","filed_at":"2024-10-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:07.861062+00:00","generated_at":"2026-05-30T08:02:11.210438+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Herbalife Q3 net sales $1.2B (-3.2% YoY), adjusted EBITDA $166.5M beats guidance; FY EBITDA guidance raised","bullets":["Net sales $1.2B, down 3.2% YoY (flat constant currency); net income $47.4M, diluted EPS $0.46.","Adjusted net income $58.0M, adjusted diluted EPS $0.57; adjusted EBITDA $166.5M, margin up 70bps YoY.","Pre-tax gain on sale of property ~$4M; net cash from ops $99.5M; leverage ratio reduced to 3.3x.","Full-year 2024 guidance: net sales range narrowed, adjusted EBITDA raised, capex top end reduced.","Credit Agreement EBITDA $197.2M; total leverage ratio 3.3x at quarter end."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-092256","json":"https://secwatch.observer/filing/0001213900-24-092256.json","markdown":"https://secwatch.observer/filing/0001213900-24-092256.md","text":"https://secwatch.observer/filing/0001213900-24-092256.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1180262/000121390024092256/0001213900-24-092256-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1180262/000121390024092256/ea0218931-8k_herbalife.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T08:02:11.210438+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}